Loading
NASDAQFinancial ServicesFinancial - Conglomerates
Latest quote
$0.07
+$0.0051 · +7.86%
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
Latest quote
$0.07
+$0.0051 · +7.86%
Regular session · ET · Market data may be delayed.
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
Day range
Current $0.07
52-week range
Current $0.07
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
85
Deep Value
Sentiment
58
Mixed
Risk
59
Elevated Risk
Momentum
25
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
Day range
Current $0.07
52-week range
Current $0.07
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 |
|---|---|---|
| Selling, general, and administrative | 1.3M USD | 151.72K USD |
| Operating expenses | 1.3M USD | 151.72K USD |
| Interest income | 4.93M USD | — |
| Operating income | −1.3M USD | −151.72K USD |
| Net income | 4.19M USD | −151.72K USD |
Company facts updated Oct 9, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
